Ghazal Jameel

NPI: 1902237548
Total Payments
$40,059
2024 Payments
$355.00
Companies
8
Transactions
115
Medicare Patients
1,048
Medicare Billing
$152,396

Payment Breakdown by Category

Other$26,005 (64.9%)
Travel$8,154 (20.4%)
Consulting$3,269 (8.2%)
Food & Beverage$2,247 (5.6%)
Education$384.34 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $22,005 22 54.9%
Travel and Lodging $8,154 46 20.4%
Compensation for serving as faculty or as a speaker for a medical education program $4,000 3 10.0%
Consulting Fee $3,269 4 8.2%
Food and Beverage $2,247 33 5.6%
Education $384.34 7 1.0%

Top Paying Companies

Company Total Records Latest Year
AVEO Pharmaceuticals, Inc. $25,468 66 $0 (2023)
GENZYME CORPORATION $13,554 33 $0 (2023)
Exelixis Inc. $443.64 11 $0 (2024)
Bayer HealthCare Pharmaceuticals Inc. $354.00 1 $0 (2021)
Astellas Pharma Global Development $116.44 1 $0 (2024)
AstraZeneca Pharmaceuticals LP $84.47 1 $0 (2024)
Janssen Scientific Affairs, LLC $22.62 1 $0 (2024)
PFIZER INC. $15.20 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $355.00 8 Astellas Pharma Global Development ($116.44)
2023 $8,015 26 AVEO Pharmaceuticals, Inc. ($7,641)
2022 $27,843 71 AVEO Pharmaceuticals, Inc. ($14,335)
2021 $3,846 10 Aveo Pharmaceuticals, Inc. ($3,492)

All Payment Transactions

115 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/18/2024 Astellas Pharma Global Development Padcev (Drug) Food and Beverage In-kind items and services $116.44 General
Category: Oncology
12/17/2024 PFIZER INC. XTANDI (Drug) Food and Beverage In-kind items and services $15.20 General
Category: ONCOLOGY
11/21/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $23.57 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
09/12/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $17.74 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
07/18/2024 Janssen Scientific Affairs, LLC ERLEADA (Drug), AKEEGA Food and Beverage In-kind items and services $22.62 General
Category: Oncology
04/24/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $41.98 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
03/07/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $32.98 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
02/28/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $84.47 General
Category: Oncology
12/18/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Travel and Lodging Cash or cash equivalent $321.06 General
Category: Oncology
12/18/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Food and Beverage Cash or cash equivalent $79.05 General
Category: Oncology
12/12/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,700.00 General
Category: Oncology
12/07/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Travel and Lodging In-kind items and services $349.89 General
Category: Oncology
12/07/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Travel and Lodging In-kind items and services $119.60 General
Category: Oncology
12/07/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Food and Beverage In-kind items and services $67.87 General
Category: Oncology
12/05/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Travel and Lodging Cash or cash equivalent $214.84 General
Category: Oncology
12/05/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Travel and Lodging Cash or cash equivalent $41.13 General
Category: Oncology
12/05/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Food and Beverage Cash or cash equivalent $15.27 General
Category: Oncology
12/05/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Travel and Lodging Cash or cash equivalent $5.00 General
Category: Oncology
11/29/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,000.00 General
Category: Oncology
11/20/2023 Exelixis Inc. Education In-kind items and services $41.20 General
11/15/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,300.00 General
Category: Oncology
11/15/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Food and Beverage In-kind items and services $123.98 General
Category: Oncology
11/09/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Travel and Lodging In-kind items and services $198.24 General
Category: Oncology
11/09/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Food and Beverage In-kind items and services $94.58 General
Category: Oncology
08/10/2023 Exelixis Inc. Education In-kind items and services $44.97 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 279 726 $127,980 $45,159
2022 1 268 671 $113,533 $41,867
2021 1 227 597 $92,001 $38,337
2020 2 274 554 $79,262 $27,033
Total Patients
1,048
Total Services
2,548
Medicare Billing
$152,396
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 262 708 $125,775 $44,343 35.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 17 18 $2,205 $816.30 37.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 249 652 $110,341 $40,606 36.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 19 19 $3,192 $1,261 39.5%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 227 597 $92,001 $38,337 41.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 194 454 $69,462 $24,649 35.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 80 100 $9,800 $2,383 24.3%

About Ghazal Jameel

Ghazal Jameel is a Nurse Practitioner healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2013. The National Provider Identifier (NPI) number assigned to this provider is 1902237548.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ghazal Jameel has received a total of $40,059 in payments from pharmaceutical and medical device companies, with $355.00 received in 2024. These payments were reported across 115 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,005).

As a Medicare-enrolled provider, Jameel has provided services to 1,048 Medicare beneficiaries, totaling 2,548 services with total Medicare billing of $152,396. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Tampa, FL
  • Active Since 12/09/2013
  • Last Updated 03/25/2025
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1902237548

Products in Payments

  • FOTIVDA (Drug) $25,468
  • JEVTANA (Drug) $12,924
  • Nubeqa (Drug) $354.00
  • CABOMETYX (Drug) $143.80
  • Padcev (Drug) $116.44
  • LYNPARZA (Drug) $84.47
  • ERLEADA (Drug) $22.62
  • XTANDI (Drug) $15.20

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Tampa